Transancestral fine-mapping of four type 2 diabetes susceptibility loci highlights potential causal regulatory mechanisms.

Hum Mol Genet
Authors
Abstract

To gain insight into potential regulatory mechanisms through which the effects of variants at four established type 2 diabetes (T2D) susceptibility loci (CDKAL1, CDKN2A-B, IGF2BP2 and KCNQ1) are mediated, we undertook transancestral fine-mapping in 22 086 cases and 42 539 controls of East Asian, European, South Asian, African American and Mexican American descent. Through high-density imputation and conditional analyses, we identified seven distinct association signals at these four loci, each with allelic effects on T2D susceptibility that were homogenous across ancestry groups. By leveraging differences in the structure of linkage disequilibrium between diverse populations, and increased sample size, we localised the variants most likely to drive each distinct association signal. We demonstrated that integration of these genetic fine-mapping data with genomic annotation can highlight potential causal regulatory elements in T2D-relevant tissues. These analyses provide insight into the mechanisms through which T2D association signals are mediated, and suggest future routes to understanding the biology of specific disease susceptibility loci.

Year of Publication
2016
Journal
Hum Mol Genet
Volume
25
Issue
10
Pages
2070-2081
Date Published
2016 May 15
ISSN
1460-2083
URL
DOI
10.1093/hmg/ddw048
PubMed ID
26911676
PubMed Central ID
PMC5062576
Links
Grant list
R01 DK078616 / DK / NIDDK NIH HHS / United States
G0700931 / Medical Research Council / United Kingdom
R01 DK072193 / DK / NIDDK NIH HHS / United States
G0601966 / Medical Research Council / United Kingdom
U01 DK105535 / DK / NIDDK NIH HHS / United States
P30 DK020541 / DK / NIDDK NIH HHS / United States
U01 DK078616 / DK / NIDDK NIH HHS / United States
P30 DK020572 / DK / NIDDK NIH HHS / United States
G0601261 / Medical Research Council / United Kingdom
RP-PG-0407-10371 / Department of Health / United Kingdom
P30 DK020595 / DK / NIDDK NIH HHS / United States